Phase 1 proof-of-concept study of CLY-124 in Sickle Cell Disease expected in Q4 2026In vivo preclinical data assessing new compounds vs. standard of care in gold-standard, translatable myelofibrosis ...
Illumina, whose EMEA head office is at Granta Park in Cambridge, has released Illumina Connected Multiomics, a powerful cloud ...
The field of immunotherapy has revolutionized the treatment of advanced non-small cell lung cancer (NSCLC), particularly ...
Researchers developed two computational tools to decode how cells communicate in tissues. sCCIgen creates realistic virtual ...
In a paper published in the journal Nature Neuroscience, researchers have mapped how stress events during pregnancy can ...
Illumina, Inc. (NASDAQ: ILMN) today announced the release of Illumina Connected Multiomics, a powerful cloud-based research ...
The pelvis is often called the keystone of upright movement. It helps explain how human ancestors left life on all fours ...
Cancer is the second leading cause of death worldwide. Since age is one of the risk factors for the development of cancer, ...
The human brain is a fascinating and complex organ that supports numerous sophisticated behaviors and abilities that are ...
STORIES is a trajectory inference method capable of learning a causal model of cellular differentiation from spatial transcriptomics through time using Fused Gromov-Wasserstein. STORIES learns a ...
Transcriptomics Data Analysis (TDA) is a live, instructor-led training program designed to introduce participants to best practices in the analysis of high-throughput RNA sequencing (RNA-seq) data.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback